Download Content

TNFR2 And PD1 Resistance

Please enter your details into the form below to access the Webinar on ‘TNFR2 And PD1 Resistance‘. Hosted by Russell LaMontagne, Co-Founder and Chief Executive Officer, Boston Immune Technologies and Therapeutics.